Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medication Non-Adherence To Be Examined By Surgeon General

This article was originally published in The Pink Sheet Daily

Executive Summary

The HHS Office of the Surgeon General issues a request for information regarding the non-adherence of prescription medication. However, it is unclear how it plans to use the information once it is collected.

You may also be interested in...



EHRs A Tool For Drug Label Communications, Adverse Event Reporting And Adherence – FDA’s Woodcock

FDA’s vision for electronic health records is being incorporated into a new application launched by PDR Network.

Good News, Bad News On Medication Adherence: Problem Understood, Now How To Fix Human Behavior?

The Centers for Medicare and Medicaid Services’ long awaited final rules on Accountable Care Organizations, issued on Oct. 20, include encouraging incentives for medication adherence. That’s good news for the industry, but it also throws a spotlight on the imperfect state of medication adherence methodologies.

Pharmacy-Related Waste Exceeded $403 Billion In 2010 – Express Scripts

Pharmacy benefits manager Express Scripts reported that in 2010, $403 billion in pharmacy-related waste could have been avoided across three areas – the sales channel, generic utilization and nonadherence to medications.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS073976

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel